ID   KPCT_HUMAN              Reviewed;         706 AA.
AC   Q04759; Q14DH6; Q3MJF1; Q64FY5; Q9H508; Q9H549;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   27-MAR-2002, sequence version 3.
DT   05-OCT-2010, entry version 127.
DE   RecName: Full=Protein kinase C theta type;
DE            EC=2.7.11.13;
DE   AltName: Full=nPKC-theta;
GN   Name=PRKCQ; Synonyms=PRKCT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT LEU-330.
RX   MEDLINE=93300813; PubMed=7686153;
RA   Chang J.D., Xu Y., Raychowdhury M.K., Ware J.A.;
RT   "Molecular cloning and expression of a cDNA encoding a novel isoenzyme
RT   of protein kinase C (nPKC). A new member of the nPKC family expressed
RT   in skeletal muscle, megakaryoblastic cells, and platelets.";
RL   J. Biol. Chem. 268:14208-14214(1993).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RX   PubMed=7983077;
RA   Chang J.D., Xu Y., Raychowdhury M.K., Ware J.A.;
RL   J. Biol. Chem. 269:31322-31322(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   MEDLINE=93186810; PubMed=8444877;
RA   Baier G., Telford D., Giampa L., Coggeshall K.M., Baier-Bitterlich G.,
RA   Isakov N., Altman A.;
RT   "Molecular cloning and characterization of PKC theta, a novel member
RT   of the protein kinase C (PKC) gene family expressed predominantly in
RT   hematopoietic cells.";
RL   J. Biol. Chem. 268:4997-5004(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT LEU-330.
RA   Li H., Ke R., Zhou G., Shen C., Zhong G., Lin L., Yang S.;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH GLRX3.
RX   MEDLINE=20102703; PubMed=10636891; DOI=10.1074/jbc.275.3.1902;
RA   Witte S., Villalba M., Bi K., Liu Y., Isakov N., Altman A.;
RT   "Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways
RT   by PICOT, a novel protein kinase C-interacting protein with a
RT   thioredoxin homology domain.";
RL   J. Biol. Chem. 275:1902-1909(2000).
RN   [8]
RP   FUNCTION, PHOSPHORYLATION AT THR-219; THR-538; SER-676 AND SER-695,
RP   AND MUTAGENESIS OF THR-219; THR-538; SER-676 AND SER-695.
RX   PubMed=16252004; DOI=10.1038/sj.emboj.7600856;
RA   Thuille N., Heit I., Fresser F., Krumbock N., Bauer B.,
RA   Leuthaeusser S., Dammeier S., Graham C., Copeland T.D., Shaw S.,
RA   Baier G.;
RT   "Critical role of novel Thr-219 autophosphorylation for the cellular
RT   function of PKCtheta in T lymphocytes.";
RL   EMBO J. 24:3869-3880(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-538; SER-685 AND
RP   SER-695, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348; SER-676; SER-685
RP   AND SER-695, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-536; SER-657; SER-676;
RP   SER-685 AND SER-695, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-384, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-240; VAL-306; LEU-330 AND ASN-354.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This is a calcium-independent, phospholipid-dependent,
CC       serine- and threonine-specific enzyme. Essential for T-cell
CC       receptor (TCR)-mediated T-cell activation, but is dispensable
CC       during TCR-dependent thymocyte development. Links the TCR
CC       signaling complex to the activation of NF-kappa-B in mature T
CC       lymphocytes. Required for interleukin-2 (IL2) production.
CC   -!- FUNCTION: PKC is activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. PKC also serves as
CC       the receptor for phorbol esters, a class of tumor promoters.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Three specific sites; Thr-538 (activation loop
CC       of the kinase domain), Ser-676 (turn motif) and Ser-695
CC       (hydrophobic region), need to be phosphorylated for its full
CC       activation.
CC   -!- SUBUNIT: Interacts with GLRX3 (via N-terminus).
CC   -!- INTERACTION:
CC       Q06187:BTK; NbExp=2; IntAct=EBI-374762, EBI-624835;
CC       P06241:FYN; NbExp=6; IntAct=EBI-374762, EBI-515315;
CC       O76003:GLRX3; NbExp=2; IntAct=EBI-374762, EBI-374781;
CC       Q05513:PRKCZ; NbExp=2; IntAct=EBI-374762, EBI-295351;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q04759-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q04759-2; Sequence=VSP_017294;
CC   -!- TISSUE SPECIFICITY: Skeletal muscle, megakaryoblastic cells and
CC       platelets.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type
CC       region 1 (C1A) and 2 (C1B), is the diacylglycerol sensor and the
CC       C2 domain is a non-calcium binding domain.
CC   -!- PTM: Autophosphorylation at Thr-219 is required for targeting to
CC       the TCR and cellular function of PKC upon antigen receptor
CC       ligation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L01087; AAA75571.1; -; mRNA.
DR   EMBL; L07032; AAA60101.1; -; mRNA.
DR   EMBL; AY702977; AAU29340.1; -; mRNA.
DR   EMBL; AL158043; CAC12904.2; -; Genomic_DNA.
DR   EMBL; AL137145; CAC10200.2; -; Genomic_DNA.
DR   EMBL; BC101465; AAI01466.1; -; mRNA.
DR   EMBL; BC113359; AAI13360.1; -; mRNA.
DR   IPI; IPI00029196; -.
DR   IPI; IPI00470691; -.
DR   PIR; A45416; A45416.
DR   RefSeq; NP_006248.1; -.
DR   UniGene; Hs.498570; -.
DR   PDB; 1XJD; X-ray; 2.00 A; A=362-706.
DR   PDB; 2ENJ; NMR; -; A=1-126.
DR   PDB; 2ENN; NMR; -; A=144-213.
DR   PDB; 2ENZ; NMR; -; A=227-284.
DR   PDB; 2JED; X-ray; 2.32 A; A/B=361-706.
DR   PDBsum; 1XJD; -.
DR   PDBsum; 2ENJ; -.
DR   PDBsum; 2ENN; -.
DR   PDBsum; 2ENZ; -.
DR   PDBsum; 2JED; -.
DR   ProteinModelPortal; Q04759; -.
DR   SMR; Q04759; 133-252.
DR   IntAct; Q04759; 21.
DR   MINT; MINT-4649766; -.
DR   STRING; Q04759; -.
DR   PhosphoSite; Q04759; -.
DR   PRIDE; Q04759; -.
DR   Ensembl; ENST00000263125; ENSP00000263125; ENSG00000065675.
DR   GeneID; 5588; -.
DR   KEGG; hsa:5588; -.
DR   UCSC; uc001iji.1; human.
DR   UCSC; uc009xim.1; human.
DR   CTD; 5588; -.
DR   GeneCards; GC10M006509; -.
DR   H-InvDB; HIX0025956; -.
DR   HGNC; HGNC:9410; PRKCQ.
DR   MIM; 600448; gene.
DR   PharmGKB; PA33773; -.
DR   eggNOG; prNOG10333; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q04759; -.
DR   OMA; QRRGAIK; -.
DR   OrthoDB; EOG95F081; -.
DR   PhylomeDB; Q04759; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; nfat_tfpathway; Calcineurin-regulated NFAT-dependent transcription in lymphocytes.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21674; -.
DR   PMAP-CutDB; Q04759; -.
DR   ArrayExpress; Q04759; -.
DR   Bgee; Q04759; -.
DR   CleanEx; HS_PRKCQ; -.
DR   Genevestigator; Q04759; -.
DR   GermOnline; ENSG00000065675; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004697; F:protein kinase C activity; IEA:EC.
DR   GO; GO:0023034; P:intracellular signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; NAS:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; NAS:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; FALSE_NEG.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    706       Protein kinase C theta type.
FT                                /FTId=PRO_0000055708.
FT   DOMAIN        8    123       C2.
FT   DOMAIN      380    634       Protein kinase.
FT   DOMAIN      635    706       AGC-kinase C-terminal.
FT   ZN_FING     159    209       Phorbol-ester/DAG-type 1.
FT   ZN_FING     231    281       Phorbol-ester/DAG-type 2.
FT   NP_BIND     386    394       ATP (By similarity).
FT   ACT_SITE    504    504       Proton acceptor (By similarity).
FT   BINDING     409    409       ATP.
FT   MOD_RES     219    219       Phosphothreonine; by autocatalysis.
FT   MOD_RES     348    348       Phosphoserine.
FT   MOD_RES     384    384       N6-acetyllysine.
FT   MOD_RES     536    536       Phosphothreonine.
FT   MOD_RES     538    538       Phosphothreonine.
FT   MOD_RES     657    657       Phosphoserine.
FT   MOD_RES     676    676       Phosphoserine.
FT   MOD_RES     685    685       Phosphoserine.
FT   MOD_RES     695    695       Phosphoserine.
FT   VAR_SEQ     550    612       Missing (in isoform 2).
FT                                /FTId=VSP_017294.
FT   VARIANT     240    240       K -> N (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042319.
FT   VARIANT     306    306       D -> V (in dbSNP:rs45590231).
FT                                /FTId=VAR_042320.
FT   VARIANT     330    330       P -> L (in dbSNP:rs2236379).
FT                                /FTId=VAR_020401.
FT   VARIANT     354    354       D -> N (in dbSNP:rs34524148).
FT                                /FTId=VAR_042321.
FT   MUTAGEN     219    219       T->A: Loss of transactivation of the IL2
FT                                promoter and translocation to the plasma
FT                                membrane. No effect on kinase activity.
FT   MUTAGEN     409    409       K->A: Loss of kinase activity.
FT   MUTAGEN     538    538       T->A: Loss of kinase activity.
FT   MUTAGEN     676    676       S->A: Reduction in kinase activity.
FT   MUTAGEN     695    695       S->A: Reduction in kinase activity.
FT   CONFLICT    700    700       G -> R (in Ref. 1; AAA75571 and 4;
FT                                AAU29340).
FT   STRAND        5     13
FT   STRAND       28     39
FT   STRAND       42     52
FT   STRAND       56     62
FT   STRAND       69     75
FT   STRAND       83     89
FT   HELIX        90     98
FT   TURN         99    101
FT   STRAND      103    108
FT   STRAND      110    112
FT   STRAND      114    121
FT   STRAND      155    159
FT   STRAND      161    165
FT   STRAND      174    176
FT   STRAND      187    189
FT   STRAND      191    193
FT   STRAND      196    199
FT   HELIX       200    202
FT   STRAND      234    236
FT   STRAND      246    248
FT   STRAND      255    257
FT   STRAND      259    265
FT   TURN        271    276
FT   TURN        281    283
FT   STRAND      380    388
FT   STRAND      390    399
FT   TURN        400    402
FT   STRAND      405    412
FT   HELIX       413    418
FT   HELIX       422    435
FT   STRAND      444    449
FT   STRAND      451    459
FT   HELIX       466    473
FT   HELIX       478    497
FT   HELIX       507    509
FT   STRAND      510    512
FT   STRAND      518    520
FT   HELIX       543    545
FT   HELIX       548    551
FT   HELIX       559    574
FT   HELIX       584    593
FT   HELIX       604    613
FT   HELIX       618    620
FT   HELIX       628    630
FT   HELIX       632    634
FT   HELIX       639    643
FT   TURN        690    693
FT   HELIX       701    706
SQ   SEQUENCE   706 AA;  81865 MW;  B3C53AB892D5210A CRC64;
     MSPFLRIGLS NFDCGSCQSC QGEAVNPYCA VLVKEYVESE NGQMYIQKKP TMYPPWDSTF
     DAHINKGRVM QIIVKGKNVD LISETTVELY SLAERCRKNN GKTEIWLELK PQGRMLMNAR
     YFLEMSDTKD MNEFETEGFF ALHQRRGAIK QAKVHHVKCH EFTATFFPQP TFCSVCHEFV
     WGLNKQGYQC RQCNAAIHKK CIDKVIAKCT GSAINSRETM FHKERFKIDM PHRFKVYNYK
     SPTFCEHCGT LLWGLARQGL KCDACGMNVH HRCQTKVANL CGINQKLMAE ALAMIESTQQ
     ARCLRDTEQI FREGPVEIGL PCSIKNEARP PCLPTPGKRE PQGISWESPL DEVDKMCHLP
     EPELNKERPS LQIKLKIEDF ILHKMLGKGS FGKVFLAEFK KTNQFFAIKA LKKDVVLMDD
     DVECTMVEKR VLSLAWEHPF LTHMFCTFQT KENLFFVMEY LNGGDLMYHI QSCHKFDLSR
     ATFYAAEIIL GLQFLHSKGI VYRDLKLDNI LLDKDGHIKI ADFGMCKENM LGDAKTNTFC
     GTPDYIAPEI LLGQKYNHSV DWWSFGVLLY EMLIGQSPFH GQDEEELFHS IRMDNPFYPR
     WLEKEAKDLL VKLFVREPEK RLGVRGDIRQ HPLFREINWE ELERKEIDPP FRPKVKSPFD
     CSNFDKEFLN EKPRLSFADR ALINSMDQNM FRNFSFMNPG MERLIS
//
